Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB26FL5C9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,168
Award facts
- Contract value 100% obligated
- $31,167.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,167.92 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL prefilled pen auto-injectors on November 5, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by November 6, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as the company's comprehensive global pharmaceutical support vehicle for military healthcare systems.
As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a broad portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a biologic immunosuppressant medication used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, representing the type of specialty pharmaceutical product routinely procured through DLA's medical supply chain to support military personnel and veterans. This award demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition and its role as a critical vendor within the Department of Defense's pharmaceutical distribution network.
Quick answers
Who was awarded contract SPE2DB26FL5C9?
SPE2DB26FL5C9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FL5C9 worth?
The government has obligated $31,168 on SPE2DB26FL5C9.
Is contract SPE2DB26FL5C9 an order under another contract?
Yes. SPE2DB26FL5C9 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB26FL5C9 competed?
The extent of competition for SPE2DB26FL5C9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award